Second Sight Medical Products announces it has completed US phase 1 enrollment for FDA-approved clinical studies and is commencing European clinical trials for the Argus II Retinal Implant.
Canadian radio station Whistler FM has a system which will improve the prospects of the visually-impaired to work in the radio industry.
4 min
About Vision Treatment Advances
From the publisher's feed
Max Flehinger, former AIRSLA President, selects and reads articles on recent advances in vision treatment from a variety of prominent vision treatment journals and seminars.